E
Evaheart Medical USA
Rotary pump yet pulsatile
About Evaheart Medical USA
Evaheart USA is a medical technology startup that specializes in the development and distribution of advanced heart assist devices. Their flagship product, the EVA2, is a Left Ventricular Assist Device (LVAD) that employs a unique centrifugal pump design to support blood circulation. This device is particularly beneficial for patients with severe heart conditions, as it aids in maintaining the natural pulsatility of the heart.
The EVA2's innovative design includes a hydraulically levitated impeller, which is a type of rotor used to increase the pressure and flow of blood. This impeller is lubricated with sterile water to minimize the risk of clot formation, a common complication in heart assist devices. The device also features a novel double cuff tipless inflow cannula, a tube inserted into the heart to help pump blood, designed to improve anatomical fitting and potentially reduce post-LVAD stroke.
Evaheart USA operates in the medical device market, specifically targeting the cardiovascular sector. Their business model revolves around the development, production, and sale of their heart assist devices to healthcare providers. The company generates revenue through the sale of these devices, which are then used by medical professionals to treat patients with severe heart conditions.
In summary, Evaheart USA is a promising startup in the medical technology sector, offering innovative solutions for severe heart conditions. Their unique product design and focus on patient safety position them well in the growing cardiovascular device market.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Mar 2023 | $100M | $400M | Vivo Capital · Taiping Medical and Health Fund · Sinovac Biotech | ↗ |
| SPINOUTOther financing | Jan 2014 | $0 | — | Tokyo Women's Medial College | — |
Growth signals
Latest recorded traffic for Evaheart Medical USA is 1.1K monthly website visits, down 31.3% over the last three months. Evaheart Medical USA's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Evaheart Medical USA in its local ecosystem
The Evaheart Medical USA office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sinovac Biotech
Vivo Capital- TFTaiping Medical and Health Fund
Other known investors1 additional known investor
Tokyo Women's Medial College
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evaheart Medical USA on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evaheart Medical USA’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








